Topics

No keywords indexed for this article. Browse by subject →

References
32
[1]
Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987–995 (2004). 10.1038/ni1112
[2]
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006). 10.1016/j.cell.2006.02.015
[3]
Svanborg, C. et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr. Opin. Microbiol. 9, 33–39 (2006). 10.1016/j.mib.2005.12.012
[4]
Takeuchi, O., Hoshino, K. & Akira, S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to staphylococcus aureus infection. J. Immunol. 165, 5392–5396 (2000). 10.4049/jimmunol.165.10.5392
[5]
Abel, B. et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169, 3155–3162 (2002). 10.4049/jimmunol.169.6.3155
[6]
Torres, D. et al. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infect. Immun. 72, 2131–2139 (2004). 10.1128/iai.72.4.2131-2139.2004
[7]
Rodriguez, N. et al. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae. Eur. J. Immunol. 36, 1145–1155 (2006). 10.1002/eji.200535152
[8]
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998). 10.1126/science.282.5396.2085
[9]
TLR signaling

T Kawai, S Akira

Cell Death & Differentiation 2006 10.1038/sj.cdd.4401850
[10]
Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263–268 (2003). 10.1084/jem.20021790
[11]
Bowie, A. et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97, 10162–10167 (2000). 10.1073/pnas.160027697
[12]
Harte, M.T. et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197, 343–351 (2003). 10.1084/jem.20021652
[13]
Stack, J. et al. Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201, 1007–1018 (2005). 10.1084/jem.20041442
[14]
Newman, R.M., Salunkhe, P., Godzik, A. & Reed, J.C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74, 594–601 (2006). 10.1128/iai.74.1.594-601.2006
[15]
Radons, J. et al. The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites in vitro mutagenesis and molecular modeling. J. Biol. Chem. 278, 49145–49153 (2003). 10.1074/jbc.m306077200
[16]
Costa, C.P. et al. Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur. J. Immunol. 32, 2460–2470 (2002). 10.1002/1521-4141(200209)32:9<2460::aid-immu2460>3.0.co;2-m
[17]
Lafont, F. & van der Goot, F.G. Bacterial invasion via lipid rafts. Cell. Microbiol. 7, 613–620 (2005). 10.1111/j.1462-5822.2005.00515.x
[18]
Pannek, S. et al. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J. Antimicrob. Chemother. 57, 970–974 (2006). 10.1093/jac/dkl081
[19]
Frendeus, B. et al. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol. Microbiol. 40, 37–51 (2001). 10.1046/j.1365-2958.2001.02361.x
[20]
Samuelsson, P., Hang, L., Wullt, B., Irjala, H. & Svanborg, C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect. Immun. 72, 3179–3186 (2004). 10.1128/iai.72.6.3179-3186.2004
[21]
Gorvel, J.P. & Moreno, E. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 90, 281–297 (2002). 10.1016/s0378-1135(02)00214-6
[22]
Delrue, R.M. et al. Identification of Brucella spp. genes involved in intracellular trafficking. Cell. Microbiol. 3, 487–497 (2001). 10.1046/j.1462-5822.2001.00131.x
[23]
Comerci, D.J., Martinez-Lorenzo, M.J., Sieira, R., Gorvel, J.P. & Ugalde, R.A. Essential role of the VirB machinery in the maturation of the Brucella abortus–containing vacuole. Cell. Microbiol. 3, 159–168 (2001). 10.1046/j.1462-5822.2001.00102.x
[24]
Lapaque, N., Moriyon, I., Moreno, E. & Gorvel, J.P. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60–66 (2005). 10.1016/j.mib.2004.12.003
[25]
Sola-Landa, A. et al. A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol. Microbiol. 29, 125–138 (1998). 10.1046/j.1365-2958.1998.00913.x
[26]
Detilleux, P.G., Deyoe, B.L. & Cheville, N.F. Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect. Immun. 58, 2320–2328 (1990). 10.1128/iai.58.7.2320-2328.1990
[27]
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli

Rodney A. Welch, V. Burland, G. Plunkett et al.

Proceedings of the National Academy of Sciences 2002 10.1073/pnas.252529799
[28]
Kern, W.V. et al. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57, 339–343 (2006). 10.1093/jac/dki445
[29]
Schumacher, A. et al. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J. Antimicrob. Chemother. 57, 344–348 (2006). 10.1093/jac/dki446
[30]
Hagberg, L. et al. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect. Immun. 40, 265–272 (1983). 10.1128/iai.40.1.265-272.1983
[31]
Bean, M.A., Pees, H., Fogh, J.E., Grabstald, H. & Oettgen, H.F. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3- H-proline microcytotoxicity test. Int. J. Cancer 14, 186–197 (1974). 10.1002/ijc.2910140207
[32]
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Kirill A. Datsenko, Barry L. Wanner

Proceedings of the National Academy of Sciences 2000 10.1073/pnas.120163297
Metrics
328
Citations
32
References
Details
Published
Mar 09, 2008
Vol/Issue
14(4)
Pages
399-406
License
View
Cite This Article
Christine Cirl, Andreas Wieser, Manisha Yadav, et al. (2008). Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins. Nature Medicine, 14(4), 399-406. https://doi.org/10.1038/nm1734
Related

You May Also Like

The biology of VEGF and its receptors

Napoleone Ferrara, Hans-Peter Gerber · 2003

7,614 citations

Microenvironmental regulation of tumor progression and metastasis

Daniela F Quail, Johanna A Joyce · 2013

6,673 citations

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies, Edward W. Roberts · 2018

5,090 citations